AIM: Participants in clinical trials assessing automated insulin delivery systems report perceived benefits and burdens that reflect their experiences and may predict their likelihood of uptake and continued use of this novel technology. Despite the importance of understanding their perspectives, there are no available validated and reliable measures assessing the psychosocial aspects of automated insulin delivery systems. The present study assesses the initial psychometric properties of the INSPIRE measures, which were developed for youth and adults with Type 1 diabetes, as well as parents and partners. METHODS: Data from 292 youth, 159 adults, 150 parents of youth and 149 partners of individuals recruited from the Type 1 Diabetes Exchange...
Introduction: In the last 5 years, the use of automatic insulin delivery systems has been increasing...
BACKGROUND: Patient-driven initiatives have made uptake of Do-it-Yourself Artificial Pancreas Syste...
Abstract Background Along with general measures of treatment satisfaction, treatment-specific and de...
Background: Automated insulin delivery (AID) systems have been shown to be safe and effective in red...
Abstract Background: This study identifies factors that influence satisfaction with an insulin deliv...
Background: In the HypoCOMPaSS trial, adults with long-standing type 1 diabetes and problematic hypo...
Introduction: Diabetes management in very young children remains challenging. Glycaemic targets are ...
Aims To explore the association between the use of glycaemic technologies and person-reported outco...
OBJECTIVE Assess the safety and efficacy of automated insulin delivery (AID) in adults with type 1 d...
For people with type 1 diabetes (T1DM), regular exercise can be highly beneficial. Although exercis...
To assess the impact on fear of hypoglycaemia and treatment satisfaction with an artificial pancreas...
Aims: To explore the association between the use of glycaemic technologies and person-reported outco...
Aims: To explore the psychosocial experiences of closed‐loop technology and to compare ratings of cl...
INTRODUCTION: Closed-loop systems titrate insulin based on sensor glucose levels, providing novel...
Introduction Automated insulin delivery (also known as closed loop, or artificial pancreas) ha...
Introduction: In the last 5 years, the use of automatic insulin delivery systems has been increasing...
BACKGROUND: Patient-driven initiatives have made uptake of Do-it-Yourself Artificial Pancreas Syste...
Abstract Background Along with general measures of treatment satisfaction, treatment-specific and de...
Background: Automated insulin delivery (AID) systems have been shown to be safe and effective in red...
Abstract Background: This study identifies factors that influence satisfaction with an insulin deliv...
Background: In the HypoCOMPaSS trial, adults with long-standing type 1 diabetes and problematic hypo...
Introduction: Diabetes management in very young children remains challenging. Glycaemic targets are ...
Aims To explore the association between the use of glycaemic technologies and person-reported outco...
OBJECTIVE Assess the safety and efficacy of automated insulin delivery (AID) in adults with type 1 d...
For people with type 1 diabetes (T1DM), regular exercise can be highly beneficial. Although exercis...
To assess the impact on fear of hypoglycaemia and treatment satisfaction with an artificial pancreas...
Aims: To explore the association between the use of glycaemic technologies and person-reported outco...
Aims: To explore the psychosocial experiences of closed‐loop technology and to compare ratings of cl...
INTRODUCTION: Closed-loop systems titrate insulin based on sensor glucose levels, providing novel...
Introduction Automated insulin delivery (also known as closed loop, or artificial pancreas) ha...
Introduction: In the last 5 years, the use of automatic insulin delivery systems has been increasing...
BACKGROUND: Patient-driven initiatives have made uptake of Do-it-Yourself Artificial Pancreas Syste...
Abstract Background Along with general measures of treatment satisfaction, treatment-specific and de...